Cargando…

A novel signature based on cancer-associated fibroblast genes to predict prognosis, immune feature, and therapeutic response in breast cancer

Breast cancer (BC) ranks first in the incidence of tumors in women and remains the most prevalent malignancy in women worldwide. Cancer-associated fibroblasts (CAFs) in the tumor microenvironment (TME) profoundly influence the progression, recurrence, and therapeutic resistance in BC. Here, we inten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yichen, Lv, Wenchang, Yi, Yi, Zhang, Qi, Zhang, Jun, Wu, Yiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449298/ https://www.ncbi.nlm.nih.gov/pubmed/37142271 http://dx.doi.org/10.18632/aging.204685

Ejemplares similares

A novel immune score model predicting the prognosis and immunotherapy response of breast cancer
por: Lv, Wenchang, et al.
Publicado: (2023)

Identification of an Aging-Related Gene Signature in Predicting Prognosis and Indicating Tumor Immune Microenvironment in Breast Cancer
por: Lv, Wenchang, et al.
Publicado: (2021)

Current Landscape: The Mechanism and Therapeutic Impact of Obesity for Breast Cancer
por: Zhao, Chongru, et al.
Publicado: (2021)

Identification and Validation of m6A-Related lncRNA Signature as Potential Predictive Biomarkers in Breast Cancer
por: Lv, Wenchang, et al.
Publicado: (2021)

Clinical significance for diagnosis and prognosis of POP1 and its potential role in breast cancer: a comprehensive analysis based on multiple databases
por: He, Xiao, et al.
Publicado: (2022)

Identification of pyroptosis‐related lncRNAs for constructing a prognostic model and their correlation with immune infiltration in breast cancer
por: Lv, Wenchang, et al.
Publicado: (2021)

CCDC69 is a prognostic marker of breast cancer and correlates with tumor immune cell infiltration
por: Yi, Yi, et al.
Publicado: (2022)

Landscape of prognosis and immunotherapy responsiveness under tumor glycosylation-related lncRNA patterns in breast cancer
por: Lv, Wenchang, et al.
Publicado: (2022)

A combined aging and immune prognostic signature predict prognosis and responsiveness to immunotherapy in melanoma
por: Lv, Wenchang, et al.
Publicado: (2022)

A novel pyroptosis-related indicator of immune infiltration features and prognosis in breast cancer
por: Wang, Cheng, et al.
Publicado: (2022)

Cancer-associated adipocytes: emerging supporters in breast cancer
por: Zhao, Chongru, et al.
Publicado: (2020)

Analysis and validation of m6A regulatory network: a novel circBACH2/has-miR-944/HNRNPC axis in breast cancer progression
por: Lv, Wenchang, et al.
Publicado: (2021)

Tumor-derived exosomal components: the multifaceted roles and mechanisms in breast cancer metastasis
por: Tan, Yufang, et al.
Publicado: (2021)

A novel lactate metabolism-related signature predicts prognosis and tumor immune microenvironment of breast cancer
por: Zhang, Zhihao, et al.
Publicado: (2022)

Analysis of Tumor Glycosylation Characteristics and Implications for Immune Checkpoint Inhibitor’s Efficacy for Breast Cancer
por: Lv, Wenchang, et al.
Publicado: (2022)

Circular RNAs: Their Role in the Pathogenesis and Orchestration of Breast Cancer
por: He, Xiao, et al.
Publicado: (2021)

Breast Reconstruction Does Not Affect the Survival of Patients with Breast Cancer Located in the Central and Nipple Portion: A Surveillance, Epidemiology, and End Results Database Analysis
por: Xiong, Mingchen, et al.
Publicado: (2022)

Predicting the immune microenvironment and prognosis with a anoikis - related signature in breast cancer
por: Lu, Xiuqing, et al.
Publicado: (2023)

The pleiotropic roles of adipocyte secretome in remodeling breast cancer
por: Zhou, Xiaomei, et al.
Publicado: (2022)

The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer
por: Mak, Tsz Kin, et al.
Publicado: (2022)

Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer
por: Wang, Zitao, et al.
Publicado: (2022)

Machine Learning-Devised Immune-Related lncRNA Signature Panel Predicts the Prognosis and Immune Landscape in Breast Cancer Novel IRLP Signature in BRCA
por: Zhu, Jun-Yu, et al.
Publicado: (2022)

Construction and Validation of an Immune Infiltration-Related Gene Signature for the Prediction of Prognosis and Therapeutic Response in Breast Cancer
por: Peng, Yang, et al.
Publicado: (2021)

Tumor Characterization in Breast Cancer Identifies Immune-Relevant Gene Signatures Associated With Prognosis
por: Li, Jie, et al.
Publicado: (2019)

Immunotherapy landscape analyses of necroptosis characteristics for breast cancer patients
por: Yu, Honghao, et al.
Publicado: (2022)

A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts
por: Ren, Qianhe, et al.
Publicado: (2023)

A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer
por: Ge, Weiyu, et al.
Publicado: (2022)

Identification of a novel immune signature for optimizing prognosis and treatment prediction in colorectal cancer
por: Li, Yan, et al.
Publicado: (2021)

Tumor-Derived Exosomal Non-Coding RNAs: The Emerging Mechanisms and Potential Clinical Applications in Breast Cancer
por: Yi, Yi, et al.
Publicado: (2021)

Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients
por: Jiang, Zi-Rong, et al.
Publicado: (2022)

Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma
por: Ye, Yingquan, et al.
Publicado: (2022)

Exploration the Significance of a Novel Immune-Related Gene Signature in Prognosis and Immune Microenvironment of Breast Cancer
por: Zhao, Yajie, et al.
Publicado: (2020)

The cuproptosis-related signature predicts prognosis and indicates immune microenvironment in breast cancer
por: Li, Jia, et al.
Publicado: (2022)

A Novel Immune-Related Signature to Predict Prognosis and Immune Infiltration of Cervical Cancer
por: Lin, Yun, et al.
Publicado: (2023)

Effect of activating cancer-associated fibroblasts biomarker TNC on immune cell infiltration and prognosis in breast cancer
por: Huang, Ting, et al.
Publicado: (2023)

Construction of a novel cancer-associated fibroblast-related signature to predict clinical outcome and immune response in colon adenocarcinoma
por: Zheng, Lei, et al.
Publicado: (2023)

A Genomic Signature Reflecting Fibroblast Infiltration Into Gastric Cancer Is Associated With Prognosis and Treatment Outcomes of Immune Checkpoint Inhibitors
por: Lu, Yi, et al.
Publicado: (2022)

A Pyroptosis-Related Gene Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer Based on Computational Biology Techniques
por: Wang, Zitao, et al.
Publicado: (2022)

A WGCNA-based cancer-associated fibroblast risk signature in colorectal cancer for prognosis and immunotherapy response
por: Lv, Yiming, et al.
Publicado: (2023)

Identification of a tumor immune-inflammation signature predicting prognosis and immune status in breast cancer
por: Liu, Yajing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_04c4uruj7v78b7p5c64bo7donr